Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B. Adler-Moore, J., Lewis, R. E., Brüggemann, R. J. M., Rijnders, B. J. A., Groll, A. H., & Walsh, T. J. Clinical Infectious Diseases, 68:S244 – S259, 2019. Cited by: 54; All Open Access, Green Open Access, Hybrid Gold Open Access
Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B [link]Paper  doi  bibtex   
@ARTICLE{Adler-Moore2019S244,
	author = {Adler-Moore, Jill and Lewis, Russell E. and Brüggemann, Roger J. M. and Rijnders, Bart J. A. and Groll, Andreas H. and Walsh, Thomas J.},
	title = {Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B},
	year = {2019},
	journal = {Clinical Infectious Diseases},
	volume = {68},
	pages = {S244 – S259},
	doi = {10.1093/cid/ciz064},
	url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-85068491703&doi=10.1093%2fcid%2fciz064&partnerID=40&md5=92042395a6d71346e32251e442195995},
	type = {Article},
	publication_stage = {Final},
	source = {Scopus},
	note = {Cited by: 54; All Open Access, Green Open Access, Hybrid Gold Open Access}
}

Downloads: 0